Detalhe da pesquisa
1.
Sublethal necroptosis signaling promotes inflammation and liver cancer.
Immunity
; 56(7): 1578-1595.e8, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329888
2.
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.
Gut
; 73(3): 496-508, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758326
3.
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma.
Gastroenterology
; 164(1): 72-88.e18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108710
4.
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.
PLoS Genet
; 17(6): e1009589, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166362
5.
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications.
Gut
; 72(4): 736-748, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35584893
6.
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification.
Gut
; 72(1): 129-140, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35197323
7.
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(12): 1399-1410, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039993
8.
Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer.
Mol Cancer
; 22(1): 83, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173708
9.
International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance.
J Hepatol
; 79(1): 226-239, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854345
10.
CXCR2 inhibition enables NASH-HCC immunotherapy.
Gut
; 2022 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477863
11.
Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).
Gastroenterology
; 161(3): 879-898, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34126063
12.
DNA Methylation Signatures Reveal the Diversity of Processes Remodeling Hepatocellular Carcinoma Methylomes.
Hepatology
; 74(2): 816-834, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713365
13.
Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.
Hepatology
; 74(5): 2652-2669, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157147
14.
DNA Methylation Profiling of Human Hepatocarcinogenesis.
Hepatology
; 74(1): 183-199, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33237575
15.
Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice.
Mol Ther
; 29(2): 680-690, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33554867
16.
Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer.
Gut
; 2021 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34321221
17.
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.
Br J Cancer
; 124(8): 1388-1397, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531690
18.
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.
J Hepatol
; 75(4): 865-878, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33992698
19.
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma.
Hepatology
; 71(1): 164-182, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31206197
20.
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab.
Liver Int
; 41(3): 598-607, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188713